DK0415850T3 - Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem - Google Patents

Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem

Info

Publication number
DK0415850T3
DK0415850T3 DK90402401.5T DK90402401T DK0415850T3 DK 0415850 T3 DK0415850 T3 DK 0415850T3 DK 90402401 T DK90402401 T DK 90402401T DK 0415850 T3 DK0415850 T3 DK 0415850T3
Authority
DK
Denmark
Prior art keywords
carboxymethyl
cyano
amino
metal salts
acid
Prior art date
Application number
DK90402401.5T
Other languages
Danish (da)
English (en)
Inventor
Michel Wierzbicki
Jacqueline Bonnet
Martine Brisset
Yannis Tsouderos
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0415850T3 publication Critical patent/DK0415850T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK90402401.5T 1989-09-01 1990-08-31 Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem DK0415850T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911475A FR2651497B1 (fr) 1989-09-01 1989-09-01 Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
DK0415850T3 true DK0415850T3 (da) 1994-03-21

Family

ID=9385063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90402401.5T DK0415850T3 (da) 1989-09-01 1990-08-31 Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem

Country Status (18)

Country Link
US (1) US5128367A (de)
EP (1) EP0415850B1 (de)
JP (1) JPH0692386B2 (de)
AT (1) ATE100093T1 (de)
AU (1) AU624022B2 (de)
CA (1) CA2024419C (de)
DE (2) DE69005950T2 (de)
DK (1) DK0415850T3 (de)
ES (1) ES2062450T4 (de)
FR (1) FR2651497B1 (de)
HK (1) HK57097A (de)
IE (1) IE65157B1 (de)
LU (1) LU91125I2 (de)
NL (1) NL300168I2 (de)
NZ (1) NZ234770A (de)
OA (1) OA09463A (de)
PT (1) PT95184B (de)
ZA (1) ZA906716B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
ES2394782T3 (es) * 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
WO2005082385A1 (en) * 2004-02-26 2005-09-09 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
PL1622629T3 (pl) * 2003-05-07 2013-12-31 Osteologix As Kompozycja do kontrolowanego uwalniania zawierająca sól strontu
PL1745791T3 (pl) * 2003-05-07 2013-11-29 Osteologix As Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu
US6905723B2 (en) * 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
AU2005240257B2 (en) 2004-05-06 2011-11-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
JP5070046B2 (ja) 2004-06-25 2012-11-07 モクワロ エスペーエフ エス．アー． ストロンチウムおよびビタミンｄを含む組成物およびその使用
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
EP1928855A2 (de) * 2005-08-19 2008-06-11 Glenmark Pharmaceuticals Limited Verfahren zur darstellung von strontiumranelat
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
CN101229154B (zh) * 2007-01-26 2010-05-12 鲁南制药集团股份有限公司 治疗骨质疏松的药物组合物
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
WO2010034806A1 (en) 2008-09-29 2010-04-01 Ratiopharm Gmbh Anhydrate and hydrate forms of strontium ranelate
CN101747316B (zh) * 2008-12-12 2013-09-25 重庆医药工业研究院有限责任公司 高纯度的雷奈酸锶及其制备方法
WO2010117346A2 (en) 2009-04-10 2010-10-14 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
CN101775002B (zh) * 2009-12-23 2015-07-15 浙江华海药业股份有限公司 一种制备雷尼酸锶的方法
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
IT1398542B1 (it) 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
CN102241663B (zh) * 2010-05-10 2013-02-13 山东方明药业集团股份有限公司 一种雷奈酸锶八水合物的制备方法
WO2012046251A2 (en) * 2010-10-08 2012-04-12 Glenmark Generics Limited Novel form of ranelic acid
CN102180864B (zh) * 2011-03-28 2012-12-12 中国药科大学 一种雷尼酸锶的制备方法
CZ2011320A3 (cs) 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
EP2530068A1 (de) 2011-05-31 2012-12-05 Lacer, S.A. Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose
WO2013013003A1 (en) 2011-07-21 2013-01-24 Emory University Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation
CN102503931A (zh) * 2011-09-20 2012-06-20 浙江华海药业股份有限公司 一种雷尼酸锶晶形h的制备方法
WO2013113319A1 (en) 2012-01-31 2013-08-08 Pharmathen S.A. Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (de) 2012-03-23 2013-09-25 Urquima S.A. Feste Formen von Strontiumranelat und Verfahren zu ihrer Herstellung
US8569514B1 (en) 2012-05-17 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of strontium ranelate
CN103804345B (zh) * 2013-09-06 2017-03-15 精华制药集团股份有限公司 一种用hplc法中控制备高纯度雷尼酸锶的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905577A1 (de) * 1989-02-23 1990-08-30 Basf Ag Diaminothiophene

Also Published As

Publication number Publication date
US5128367A (en) 1992-07-07
ES2062450T3 (es) 1994-12-16
PT95184A (pt) 1991-05-22
ATE100093T1 (de) 1994-01-15
HK57097A (en) 1997-05-09
ZA906716B (en) 1991-06-26
PT95184B (pt) 1997-06-30
CA2024419C (fr) 1999-07-20
JPH0692386B2 (ja) 1994-11-16
AU6203390A (en) 1991-03-07
FR2651497B1 (fr) 1991-10-25
NL300168I1 (nl) 2005-03-01
IE903162A1 (en) 1991-03-13
EP0415850A1 (de) 1991-03-06
NZ234770A (en) 1991-11-26
CA2024419A1 (fr) 1991-03-02
OA09463A (fr) 1992-11-15
FR2651497A1 (fr) 1991-03-08
IE65157B1 (en) 1995-10-04
EP0415850B1 (de) 1994-01-12
DE69005950T2 (de) 1994-07-21
DE69005950D1 (de) 1994-02-24
NL300168I2 (nl) 2005-03-01
ES2062450T4 (es) 2011-12-29
DE122005000001I1 (de) 2005-05-12
DE122005000001I2 (de) 2006-02-09
JPH03169876A (ja) 1991-07-23
LU91125I2 (fr) 2005-02-15
AU624022B2 (en) 1992-05-28

Similar Documents

Publication Publication Date Title
DK0415850T3 (da) Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO893240D0 (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
NO914217L (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2054089T3 (es) Formulaciones orales liquidas.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
IT8820116A0 (it) Il trattamento delle malattie della procedimento per la preparazione di pelle. una composizione farmaceutica per
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
IT8448370A0 (it) Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
ES2060672T3 (es) Derivados de tienoimidazol sustituidos, procedimiento para su preparacion, preparados farmaceuticos que los contienen y su utilizacion como inhibidores de la secrecion de acidos gastricos.
NO923078D0 (no) Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling
DE59003806D1 (de) Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.